Programme
| 07:00-17:00 | Registration | DKMS Symposium Click to view/download program Venue: Boardroom 1-2 |
| 08:30-10:00 | BREAKFAST SYMPOSIUM |
|
| MSD Advances in the treatment options and outcomes for melanoma patients – changing the role of the MDT Dr Dagmar Whitaker Prof Alexander Eggermont Dr Sze Wai Chan Venue: Bill Gallagher
|
||
| Session 1: Joint Plenary Covid Track Chairs: Prof Paul Ruff and Prof Vernon Louw Venue: Ballroom 2-4 |
||
| 10.30-10:40 | Opening Dr Devan Moodley and Dr Michael Cass |
|
| 10:40-11:20 | The impact of Covid-19 on Oncology Prof Georgia Demetriou |
|
| 11:20-12:00 | Covid-19 Vaccination in Oncology Prof Shabir Madhi |
|
| 12:00-12:40 | Rituximab use during the Pandemic Prof Alexander Egle |
|
| 12:40-13:00 | Panel discussion / Q&A | |
| 13:00-14:00 | LUNCH SYMPOSIUMS | |
| Pfizer The era of CDK4/6 inhibitors in the management of ER+, HER2- breast cancer: Evidence and future opportunities Professor Giuseppe Curigliano Venue: Bill Gallagher |
Sanofi Approach to the management of multiple myeloma Prof Mohamad Mohty Chair: Dr Michael Cass Venue: Committee 4 |
|
| 14:00-15:30 | Session 2 Breast Track Chairs: Prof Georgia Demetriou and Dr Dineo Tshabalala Venue: Ballroom 2-3 |
SASCeTS: Allogeneic Donor Selection Session Chair: Prof Estelle Verburgh Venue: Ballroom 4 |
| 14:00-14:30 | Importance of the CDK4/6i therapy and treatment sequencing Dr Mark Verill |
Donor selection – a complex decision requiring the weighing of a multitude of factors Prof Martin Bornhauser |
| 14:30-15:00 | Chemotherapy for Luminal MBC Dr Mark Verrill |
|
| 15:00-15:30 | Life after CDK4/6I Dr Peter Fasching |
A practical approach to donor selection in the South African context Prof Matthew Seftel |
| 15:30-16:00 | REFRESHMENT BREAK | |
| 16:00-18:00 | SASMO Conference | SASCeTS Conference |
| Session 3 Tumour Agnostic Session Chair: Dr Daleen Geldenhuys and Dr Omondi Ogude |
SASCeTS: Allogeneic Transplantation Chair: Dr Pieter de Witt |
|
| 16:00-16:30 | Introducing PARPi inhibitors Dr Susana Banerjee |
Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa? Dr Justin du Toit |
| 16:30-17:00 | Tumour Encyclopaedic Analysis Dr Chirantan Bose |
Debate: Autologous vs Allogeneic Transplant for T-cell lymphomas Dr Farah Rahman vs Dr Siphiwe Baloyi |
| 17:00-17:40 | The Neo-adjuvant Immunotherapy Revolution Prof Alexander Eggermont |
Management of steroid-resistant Graft vs Host disease Prof Robert Zeiser |
| 17:40-18:10 | Advances in IO and future directions Prof Bernardo Rapoport |
|
| 18:10 – 18:45 SASMO AGM |
18:00 – 18:30 SASCeTS AGM |
|
| 18:45-21:30 | Exhibitors Welcome Cocktail | |
| 07:00-17:00 | Registration | ||||
| 07:30-08:30 | BREAKFAST SYMPOSIUMS | ||||
|
Takeda Venue: Boardroom 6-7 |
AbbVie Venue: Boardroom 1-2 |
||||
|
Session 4: Joint Plenary |
|||||
| 09:00-09:05 | Opening of Plenary | Prof Bernardo Rapoport & Dr David Brittain |
|||
| 09:05-09:35 | Hematopoietic Stem Cell Transplantation in Multiple myeloma: Current Status & future direction | Prof Mohamad Mohty | |||
| 09:35-10:05 | Management of the cancer patient in the era of covid-19 | Prof Giuseppe Curigliano | |||
| 10:05-10:45 | Research in Africa | Dr Patrick Soon-Shiong | |||
| 10:45-11:05 | Cryopreservation and Cancer – Fertility Preservation for AYAs | Kristin Smith | |||
| 11:05-11:30 | REFRESHMENT BREAK | ||||
| 11:30-13:00 | TRACKS | ||||
|
SASMO Venue: Ballroom 2-3 |
SASCETS Venue: Ballroom 4 |
SASOPh – Venue: Committee 2 |
SASREG Venue: Committee 4 |
NURSES SYMPOSIUM Venue: Bill Gallagher |
|
| Session 5: Git Track Chairs: Dr Ashraf Wadee and Dr Mariza Tunmer |
CAR T-cell sessions Chair: Prof Vernon Louw |
Chair: Dr Johannes van Waart | |||
| 11:30-12:00 | Colon Ca Talk Prof Dirk Arnold |
CAR T-cells in ALL and DLBCL – an update on the trials Dr Partow Kebriaei |
11h30-12h15 Fundamentals of Oncology Tegan Bilse |
The Oncofertility Network in South African: A progress report Dr Chris Venter |
11:30 – 12:30 VIKING Apheresis Workshop Chair: Eileen Claassens |
| 12:00-12:20 | The clinical value of NGS and its impact on healthcare in cancer Professor Andrew Beggs |
12h15-13h00 Immunotherapy Teresa Smith |
Fertility Risk Stratification Kristen Smith |
||
| 12:20-13:00 | Surgical Talk in mCRC/HPB Prof Jean Botha |
CAR T-Cells in the treatment of multiple myeloma Prof Sham Malainkody |
Fertility Preservation in Breast cancer: Stimulation, risk and outcomes. 13:00 – 13:30 |
12:30 – 13:00 Haematology Course Caroline Rich, Igazi |
|
| 13:00-14:00 | LUNCH SYMPOSIUMS | ||||
|
Novartis Venue: Boardroom 6 -7 |
Janssen Venue: Boardroom 1-2 |
||||
| 14:00-15:40 | TRACKS | ||||
| SASMO | SASCETS | SASOPh – PHARMACISTS |
SASREG | NURSES SYMPOSIUM Sponsored by Novartis |
|
| Session 6: Lung Track Chairs: : Dr Sze-Wai Chan and Dr Duvern Ramiah |
SASCeTS CAR T-Cell Sessions Chair: Prof Vernon Louw |
14h00-14h45 Answering your GP’s question, the Drug interaction Johan Labuschagne |
Chair: Eileen Claassens |
||
| 14:00-14:30 | Lung Cancer Mutational assessment: Prof Simon Nayler |
CAR T-cells – alternatives to the commercially available platforms Dr Urbano |
Pre-Pubertal Fertility Preservation and Hormone restoration 14:30 – 15:30 Panel: Kristen Smith |
14:00 – 14:30 MDS/CASTELEMANS/MM Andrea Brummer |
|
| 14:30-15:10 | The evolution of IO from Melanoma through to lung cancer: Prof Alexander Eggermont |
14h45-15h30 Oral chemotherapy Carien v.d. Merwe |
14:30 – 15:30 |
||
| 15:10-15:40 | Searching for a drugable target: Prof Ross Camidge |
CAR T-cells in the South African context Dr David Brittain |
15h30-16h00 Advancing Oncology Pharmacy Education: The Wits Pharmacy Experience Razeeya Khan |
15:30 – 15:50 Leucophoresis Sr Murial Wentzel |
|
| 15:40-16:00 | REFRESHMENT BREAK | ||||
| 16:00-17:00 | TRACKS | ||||
| SASMO Chairs: Dr Yusuf Mayet and Dr Mia Hugo |
SASCeTS | SASOPh – PHARMACISTS |
SASREG | NURSES SYMPOSIUM Sponsored by Novartis |
|
| 16:00-16:40 |
Her2 Breast cancer: Where to next? Prof Hope Rugo |
Proffered Papers Chair: Dr Sharlene Parasnath |
16h00-16h45 Transplantation and HD chemotherapy Dr Michael Cass 16h45 – 17h00 Handover of Michael Conidaris Trophy Karin Robinson |
15:50 – 16:10 16:30 – 17:00 17:00 – 17:30 17:30 – 18:00 |
|
| 16:40-17:00 | Session 7: Proffered Papers |
||||
| 17:00-18:00 | MEET THE EXPERTS SESSIONS | ||||
| Janssen Is earlier better? Management of Advanced Prostate Cancer with Novel Therapies (Novel agents in mHSPC with thoughts on doublet vs triplet and adjuvant therapies Prof Amit Bahl Venue: Boardroom 1-2 |
Roche Venue: Committee 2 |
Janssen Venue: Boardroom 6 – 7 |
|||
| 19:00-22:30 | CONGRESS DINNER | ||||
|
Session 7: Joint Plenary |
|||
| 08:00 – 08:40 | Chemotherapy in a pandemic | Prof Hope Rugo | |
| 08:40-09:00 | Managed Health care services in Oncology | Dr Ryan Noach | |
| 09:00-10:00 | BRUNCH SYMPOSIUM | ||
| Lilly Treating aggressive MBC and patient outcomes Dr Mark Verril Venue : Boardroom 6 – 7 |
Proferred Papers Chair: Dr Vinitha Philip |
||
| 10:00-10:30 | REFRESHMENT BREAK | ||
| 10:30-12:00 | SASMO | SASCeTS | |
| Session 8: UGT Chairs: Dr Adnaan Variava and Dr Rob De Bruyne |
SASCeTS: Enhancing collaboration in South Africa Chair: Dr Karen Gunther |
||
| 10:30-11:10 | Systemic therapy for Prostate Cancer Prof Bertrand Tombal |
Quality Management Introduction: The benefits of a quality management programme Dr Andrew McDonald Starting a quality management programme Dr Jackie Thomson Analysis of QM in HSCT in SA Sr Carole Charly Discussion: How can Haematology Centres collaborate with one another to establish quality management programmes? |
|
| 11:10-11:30 | Surgery in prostate cancer Prof Shingai Mtambirwa |
||
| 11:30-11:50 | Radiotherapy in UGT Dr Sheynaz Bassa |
Collaboration between Blood SA and SASCeTS Prof Estelle Verburgh |
|
| 11:50-12:00 | Closing Address Prize Presentation | SASCeTS Closing and prize presentation | |